Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03171220
What this trial is testing

Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Not applicableActive Not RecruitingNCT07466225
What this trial is testing

HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion

Who this might be right for
Hepatocellular Carcinoma (HCC)
Peking University 150
Not applicableLooking for participantsNCT06752057
What this trial is testing

Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment

Who this might be right for
Advanced NSCLC
The First Affiliated Hospital of Nanchang University 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07751289
What this trial is testing

Anti-PD-1 Therapy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent Head and Neck Squamous Cell Carcinoma
Yanjie Zhang, MD 217
Testing effectiveness (Phase 2)Ended earlyNCT04690699
What this trial is testing

LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors

Who this might be right for
Solid TumorBladder CancerNon-muscle-invasive Bladder Cancer
Istari Oncology, Inc. 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06781112
What this trial is testing

A Phase II Study of TPF With PD-1 Inhibitor Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
TPFImmunotherapyNasopharyngeal Carcinoma+1 more
Weiwei Zhang 35
Early research (Phase 1)Not Yet RecruitingNCT07842887
What this trial is testing

Phase 1 Study of ATRA Plus a PD-1 Inhibitor in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI Resistance

Who this might be right for
EGFR-TKI-resistant Non-Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04106414
What this trial is testing

Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment

Who this might be right for
Endometrial AdenocarcinomaEndometrial Carcinosarcoma
Memorial Sloan Kettering Cancer Center 24
Early research (Phase 1)Ended earlyNCT03906526
What this trial is testing

Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhibitor in Head and Neck Cancer

Who this might be right for
Carcinoma, Squamous Cell
Celgene 15
Early research (Phase 1)WithdrawnNCT03920839
What this trial is testing

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

Who this might be right for
Advanced and/or Metastatic Solid TumorsStage IIIB Not Amenable to Curative Therapy to Stage IV Non-small Cell Lung CancerAdvanced/Metastatic Unresectable Malignant Pleural Mesothelioma
Incyte Corporation
Large-scale testing (Phase 3)UnknownNCT06017583
What this trial is testing

Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer

Who this might be right for
Rectal Neoplasms
Yong Zhang,MD 48
Testing effectiveness (Phase 2)Study completedNCT03322566
What this trial is testing

Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)

Who this might be right for
Lung Cancer
Incyte Corporation 233
Not applicableStudy completedNCT07192926
What this trial is testing

Body Composition and Blood-Based Prognostic Markers in Immunotherapy-Treated Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-small Cell Lung CancerNeoplasm
Ankara Etlik City Hospital 155
Large-scale testing (Phase 3)Looking for participantsNCT06794775
What this trial is testing

SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma

Who this might be right for
Malignant Melanoma Stage III
Hildur Helgadottir 128
Large-scale testing (Phase 3)Not Yet RecruitingNCT07445295
What this trial is testing

Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Chipscreen Biosciences, Ltd. 558
Not applicableActive Not RecruitingNCT05364086
What this trial is testing

An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
University of Rochester NCORP Research Base 2,100
Testing effectiveness (Phase 2)Study completedNCT03679767
What this trial is testing

INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

Who this might be right for
Metastatic Non-small Cell Lung CancerLocally Advanced Urothelial CancerMetastatic Urothelial Cancer+4 more
Incyte Corporation 121
Very early researchLooking for participantsNCT07319195
What this trial is testing

Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC)

Who this might be right for
Breast Cancer
Jennifer Zhang 32
Early research (Phase 1)WithdrawnNCT04892875
What this trial is testing

Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of Head and NeckOral Cavity Squamous Cell Carcinoma+7 more
Jennifer Choe
Large-scale testing (Phase 3)Looking for participantsNCT06699212
What this trial is testing

ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

Who this might be right for
Recurrent Head and Neck Squamous Cell Carcinoma
Rakuten Medical, Inc. 412
Next Page